Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation

Biochemical and Biophysical Research Communications

Volumn 310, Issue 2, 2003, Pages 421-432

  Chauhan, Sanjay ^a   Pandey, Ritu ^b   Way, Jeffrey F ^a   Sroka, Thomas C ^a   Demetriou, Manolis C ^a   Kunz, Susan ^a   Cress, Anne E ^a,c   Mount, David W ^b,c   Miesfeld, Roger L ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c University of Arizona   (United States)

Author keywords

Band 4.1; Chromogranin; Dihydrotestosterone; EPB41L4B; FERM domain; Fibronectin; HT1080; Neuroendocrine; Yurt

Indexed keywords

AMINO ACID; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CHROMOGRANIN A; DEXAMETHASONE; EZRIN; FIBRONECTIN; ISOPROTEIN; MOESIN; NEURON SPECIFIC ENOLASE; PROTEIN; PROTEIN FOUR 1; RADIXIN; STEROID; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TISSUE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; EHM 2 GENE; EXPERIMENTAL MODEL; GENE; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC CODE; GENETIC TRANSCRIPTION; GENOME ANALYSIS; GENOMICS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0141682080     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.147     Document Type: Article

References (55)

1. Schneiderman H.A., Bryant P.J. Genetic analysis of developmental mechanisms in Drosophila. Nature. 234:1971;187-194.
2. Gautreau A., Louvard D., Arpin M. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr. Opin. Cell Biol. 14:2002;104-109.
3. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4:2003;33-45.
4. Sun C.X., Robb V.A., Gutmann D.H. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J. Cell Sci. 115:2002;3991-4000.
5. Takeuchi K., Kawashima A., Nagafuchi A., Tsukita S. Structural diversity of band 4.1 superfamily members. J. Cell Sci. 107(Part 7):1994;1921-1928.
6. Han B.G., Nunomura W., Takakuwa Y., Mohandas N., Jap B.K. Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization. Nat. Struct. Biol. 7:2000;871-875.
7. Pearson M.A., Reczek D., Bretscher A., Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell. 101:2000;259-270.
8. Hamada K., Shimizu T., Matsui T., Tsukita S., Hakoshima T. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19:2000;4449-4462.
9. Shimizu T., Seto A., Maita N., Hamada K., Tsukita S., Hakoshima T. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain. J. Biol. Chem. 277:2002;10332-10336.
10. Smith W.J., Nassar N., Bretscher A., Cerione R.A., Karplus P.A. Structure of the active N-terminal domain of ezrin. J. Biol. Chem. 278:2003;4949-4956.
11. Hamada K., Shimizu T., Yonemura S., Tsukita S., Hakoshima T. Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex. EMBO J. 22:2003;502-514.
12. Nakamura F., Amieva M.R., Furthmayr H. Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. J. Biol. Chem. 270:1995;31377-31385.
13. Hirao M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., Takai Y., Tsukita S. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:1996;37-51.
14. Mangeat P., Roy C., Martin M. ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol. 9:1999;187-192.
15. Andersen J.N., Mortensen O.H., Peters G.H., Drake P.G., Iversen L.F., Olsen O.H., Jansen P.G., Andersen H.S., Tonks N.K., Moller N.P. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21:2001;7117-7136.
16. Kubo T., Yamashita T., Yamaguchi A., Sumimoto H., Hosokawa K., Tohyama M. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling. J. Neurosci. 22:2002;8504-8513.
17. Bretscher A., Edwards K., Fehon R.G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3:2002;586-599.
18. Rasheed S., Nelson-Rees W.A., Toth E.M., Arnstein P., Gardner M.B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer. 33:1974;1027-1033.
19. Bulens F., Merchiers P., Ibanez-Tallon I., De Vriese A., Nelles L., Claessens F., Belayew A., Collen D. Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator gene. J. Biol. Chem. 272:1997;663-671.
20. Miesfeld R.L. Glucocorticoid action: biochemistry. DeGroot L.J., Jameson J.L. Endocrinology. 2000;1647-1654 W.B. Saunders, Philadelphia.
21. Dean D.C., Newby R.F., Bourgeois S. Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines. J. Cell Biol. 106:1988;2159-2170.
22. Oliver N., Newby R.F., Furcht L.T., Bourgeois S. Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell. 33:1983;287-296.
23. Brenner K.A., Corbett S.A., Schwarzbauer J.E. Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene. 19:2000;3156-3163.
24. Kondoh N., Shuda M., Arai M., Oikawa T., Yamamoto M. Activation of anchorage-independent growth of HT1080 human fibrosarcoma cells by dexamethasone. In Vitro Cell Dev. Biol. Anim. 38:2002;111-117.
25. Chapman M.S., Askew D.J., Kuscuoglu U., Miesfeld R.L. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol. Endocrinol. 10:1996;967-978.
26. Gordon D.A., Chamberlain N.L., Flomerfelt F.A., Miesfeld R.L. A cell-specific and selective effect on transactivation by the androgen receptor. Exp. Cell Res. 217:1995;368-377.
27. Whitacre D.C., Karnas K.J., Miesfeld R.L. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity. Endocrine. 15:2001;111-118.
28. Whitacre D.C., Chauhan S., Davis T., Gordon D., Cress A.E., Miesfeld R. Androgen-induction of in vitro prostate cell differentiation. Cell Growth Differ. 13:2002;1-11.
29. Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186.
30. Chauhan S., Leach C.H., Kunz S., Bloom J.W., Miesfeld R.L. Glucocorticoid regulation of human eosinophil gene expression. J. Steroid Biochem. Mol. Biol. 84:2003;441-452.
31. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 95:1998;14863-14868.
32. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
33. Felsenstein J. PHYLIP-Phylogeny inference package version (3.2). Cladistics. 5:1989;164-166.
34. R.M. Schwartz, M.O. Dayhoff, B.C. Orcult, A model of evolutionary change in proteins, in: M.O. Dayhoff (Ed.), Atlas of Protein Sequence and Structure, National Biomedical Research Foundation, Washington, DC, 1978.
35. Tilley W.D., Wilson C.M., Marcelli M., McPhaul M.J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50:1990;5382-5386.
36. Wilson E.M., Oh Y., Hwa V., Rosenfeld R.G. Interaction of igf-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells. J. Clin. Endocrinol. Metab. 86:2001;4504-4511.
37. Schiemann W.P., Blobe G.C., Kalume D.E., Pandey A., Lodish H.F. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J. Biol. Chem. 277:2002;27367-27377.
38. Zhau H.Y., Chang S.M., Chen B.Q., Wang Y., Zhang H., Kao C., Sang Q.A., Pathak S.J., Chung L.W. Androgen-repressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. USA. 93:1996;15152-15157.
39. Ling M.T., Chan K.W., Choo C.K. Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line. J. Endocrinol. 170:2001;287-296.
40. Yuan S., Trachtenberg J., Mills G.B., Brown T.J., Xu F., Keating A. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. [published erratum appears in Cancer Res. 55 (3) (1995) 719] Cancer Res. 53:1993;1304-1311.
41. Heisler L.E., Evangelou A., Lew A.M., Trachtenberg J., Elsholtz H.P., Brown T.J. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol. Cell. Endocrinol. 126:1997;59-73.
42. Hashimoto Y., Shindo-Okada N., Tani M., Takeuchi K., Toma H., Yokota J. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res. 56:1996;5266-5271.
43. Shimizu K., Nagamachi Y., Tani M., Kimura K., Shiroishi T., Wakana S., Yokota J. Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells. Genomics. 65:2000;113-120.
44. Hoover K.B., Bryant P.J. Drosophila Yurt is a new protein-4.1-like protein required for epithelial morphogenesis. Dev. Genes Evol. 212:2002;230-238.
45. Koyano Y., Kawamoto T., Kikuchi A., Shen M., Kuruta Y., Tsutsumi S., Fujimoto K., Noshiro M., Fujii K., Kato Y. Chondrocyte-derived ezrin-like domain containing protein (CDEP), a rho guanine nucleotide exchange factor, is inducible in chondrocytes by parathyroid hormone and cyclic AMP and has transforming activity in NIH3T3 cells. Osteoarthr. Cartil. 9(Suppl A):2001;S64-S68.
46. Olsson P.A., Korhonen L., Mercer E.A., Lindholm D. MIR is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth. J. Biol. Chem. 274:1999;36288-36292.
47. Klarlund J.K., Holik J., Chawla A., Park J.G., Buxton J., Czech M.P. Signaling complexes of the FERM domain-containing protein GRSP1 bound to ARF exchange factor GRP1. J. Biol. Chem. 276:2001;40065-40070.
48. Takahashi K., Sasaki T., Mammoto A., Takaishi K., Kameyama T., Tsukita S., Takai Y. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272:1997;23371-23375.
49. Takahashi K., Sasaki T., Mammoto A., Hotta I., Takaishi K., Imamura H., Nakano K., Kodama A., Takai Y. Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene. 16:1998;3279-3284.
50. Perez O.D., Kinoshita S., Hitoshi Y., Payan D.G., Kitamura T., Nolan G.P., Lorens J.B. Activation of the PKB/AKT pathway by ICAM-2. Immunity. 16:2002;51-65.
51. Speck O., Hughes S.C., Noren N.K., Kulikauskas R.M., Fehon R.G. Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity. Nature. 421:2003;83-87.
52. Di Paolo G., Pellegrini L., Letinic K., Cestra G., Zoncu R., Voronov S., Chang S., Guo J., Wenk M.R., De Camilli P. Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 gamma by the FERM domain of talin. Nature. 420:2002;85-89.
53. Pang S.T., Dillner K., Wu X., Pousette A., Norstedt G., Flores-Morales A. Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology. 143:2002;4897-4906.
54. Morgan M.B., Pitha J.V. Myofibroblastoma of the breast revisited: an etiologic association with androgens? Hum. Pathol. 29:1998;347-351.
55. Wu X., Jung G., Hammer 3rd J.A. Functions of unconventional myosins. Curr. Opin. Cell Biol. 12:2000;42-51.